# Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure

> **NCT00348556** · PHASE1,PHASE2 · TERMINATED · sponsor: **Horng Chen** · enrollment: 4 (actual)

## Conditions studied

- Cardiorenal Syndrome

## Interventions

- **DRUG:** Nesiritide

## Key facts

- **NCT ID:** NCT00348556
- **Lead sponsor:** Horng Chen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Company providing catheter bought out, funding and supplies terminated
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348556, "Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00348556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*